Published online 14 July 2004
Nucleic Acids Research, Vol. 32 No. 12 © Oxford University Press 2004; all rights reserved
Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A
Institute of Cell Biology, University of Bern, Baltzerstrasse 4, 3012 Bern, Switzerland and 1 Institute of Medical Microbiology, University of Basel, Petersplatz 10, 4003 Basel, Switzerland
* To whom correspondence should be addressed. Tel: +41 31 631 4675; Fax: +41 31 631 4616; Email: daniel.schuemperli{at}izb.unibe.ch
Received as resubmission July 1, 2004; Accepted July 2, 2004
Human immunodeficiency virus 1 (HIV-1) multiplication depends on a cellular protein, cyclophilin A (CyPA), that gets integrated into viral particles. Because CyPA is not required for cell viability, we attempted to block its synthesis in order to inhibit HIV-1 replication. For this purpose, we used antisense U7 small nuclear RNAs (snRNAs) that disturb CyPA pre-mRNA splicing and short interfering RNAs (siRNAs) that target CyPA mRNA for degradation. With dual-specificity U7 snRNAs targeting the 3' and 5' splice sites of CyPA exons 3 or 4, we obtained an efficient skipping of these exons and a strong reduction of CyPA protein. Furthermore, short interfering RNAs targeting two segments of the CyPA coding region strongly reduced CyPA mRNA and protein levels. Upon lentiviral vector-mediated transduction, prolonged antisense effects were obtained for both types of antisense RNAs in the human T-cell line CEM-SS. These transduced CEM-SS cells showed a delayed, and for the siRNAs also reduced, HIV-1 multiplication. Since the two types of antisense RNAs function by different mechanisms, combining the two approaches may result in a synergistic effect.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
U. Chatterji, M. Bobardt, S. Selvarajah, F. Yang, H. Tang, N. Sakamoto, G. Vuagniaux, T. Parkinson, and P. Gallay The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication J. Biol. Chem., June 19, 2009; 284(25): 16998 - 17005. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, X. Zhao, S. Bai, Z. Wang, L. Chen, Y. Wei, and C. Huang Proteomics Identification of Cyclophilin A as a Potential Prognostic Factor and Therapeutic Target in Endometrial Carcinoma Mol. Cell. Proteomics, October 1, 2008; 7(10): 1810 - 1823. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aartsma-Rus and G.-J. B. van Ommen Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications RNA, October 1, 2007; 13(10): 1609 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Christensen, A. Daher, K. J. Soye, L. B. Frankel, M. R. Alexander, S. Laine, S. Bannwarth, C. L. Ong, S. W. L. Chung, S. M. Campbell, et al. Small Interfering RNAs against the TAR RNA Binding Protein, TRBP, a Dicer Cofactor, Inhibit Human Immunodeficiency Virus Type 1 Long Terminal Repeat Expression and Viral Production J. Virol., May 15, 2007; 81(10): 5121 - 5131. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Chatterji, M. D. Bobardt, R. Stanfield, R. G. Ptak, L. A. Pallansch, P. A. Ward, M. J. Jones, C. A. Stoddart, P. Scalfaro, J.-M. Dumont, et al. Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey Cells J. Biol. Chem., December 2, 2005; 280(48): 40293 - 40300. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goyenvalle, A. Vulin, F. Fougerousse, F. Leturcq, J.-C. Kaplan, L. Garcia, and O. Danos Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping Science, December 3, 2004; 306(5702): 1796 - 1799. [Abstract] [Full Text] [PDF] |
||||




